SCHEMBL7785173

SCHEMBL7785173

COc1ccc(C(N[C@@H](C)c2ccccc2)c2ccc(F)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
TDP1 Q9NUW8 2/20 0.45
CYP3A4 P08684 2/20 0.43
TSHR P16473 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
HTT P42858 3/20 0.43
HPGD P15428 1/20 0.43
POLB P06746 1/20 0.41
CASR P41180 2/20 0.41
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7785272 0.89 KMT2A (0.41) ALDH1A1TDP1CYP3A4CYP1A2CYP2D6
SCHEMBL7785111 0.80 CASR (0.45) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL7780324 0.80 CRHBP (0.47) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL27530332 0.80 NPC1 (0.54) ALDH1A1TDP1CYP3A4TSHRKMT2A
SCHEMBL27530335 0.80 NPC1 (0.54) ALDH1A1TDP1CYP3A4TSHRKMT2A
SCHEMBL27530409 0.78 MAPK1 (0.47) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL7785483 0.78 MAPK1 (0.47) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL7785657 0.78 SMN1; SMN2 (0.37) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL7785030 0.77 MAPT (0.56) ALDH1A1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL7784992 0.75 MAPT (0.46) ALDH1A1TDP1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329405-B1 AS ILEAL BILE ACID TRANSPORTER INHIBITOR, FOR THERAPY OF HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 2001-12-11 US disclosed
EP-1070703-A1 Cyclobutene derivatives Sankyo Company Limited (JP) 2001-01-24 EP disclosed